Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  American Journal of Pathology

• Publication date

  1992-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 1351369PMCID PMC1886533
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adhesion receptors of the immune system

  1990cited by this paper
• Fibronectins

  1990cited by this paper
• Thrombospondin in malignant and non-malignant breast tissue.

  1989cited by this paper
• Use of basement membrane markers in tumour diagnosis.

  1989cited by this paper
• Presence of type IV collagen and vitronectin in elastosis.

  1989cited by this paper
• Paucity of fibronectin in invasive lobular carcinoma of breast

  1989cited by this paper
• Thrombospondin: phenomenology to function.

  1989cited by this paper
• Detection of estrogen receptor proteins in breast tumors using an improved APAAP immunohistochemical technique

  1988cited by this paper
• Fibronectin and its receptors.

  1988cited by this paper
• The cadherins: cell-cell adhesion molecules controlling animal morphogenesis.

  1988cited by this paper
• The immunoglobulin superfamily--domains for cell surface recognition.

  1988cited by this paper
• Thrombospondin, a potentiator of tumor cell metastasis.

  1987cited by this paper
• Platelet thrombospondin mediates attachment and spreading of human melanoma cells

  1987cited by this paper
• Thrombospondin in Milk, Other Breast Secretions, and Breast Tissue

  1987cited by this paper
• Elastosis in breast carcinoma: I. Immunohistochemical characterization of elastic fibres

  1987cited by this paper
• Integrins: a family of cell surface receptors.

  1987cited by this paper
• Elastosis in breast carcinoma: II. Association of protease inhibitors with immature elastic fibres

  1987cited by this paper
• Production, Characterization, and Use of Monoclonal Antibodies Directed Against Human Blood Platelet Thrombospondin: Immunologic Comparison with Human Endothelial and Fibroblast Thrombospondins

  1987cited by this paper
• Fibronectins.

  1986cited by this paper
• Characterization of two murine monoclonal antibodies (P10, P12) directed against different determinants on human blood platelet thrombospondin.

  1986cited by this paper
• Thrombospondin-induced attachment and spreading of human squamous carcinoma cells.

  1986cited by this paper
• The structural and functional properties of thrombospondin.

  1986cited by this paper
• Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells

  1985cited by this paper
• Incorporation of thrombospondin into fibrin clots.

  1985cited by this paper
• Light microscopic immunolocation of thrombospondin in human tissues.

  1985cited by this paper
• The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects.

  1982cited by this paper
• Analysis of platelet adhesion with a radioactive chemical crosslinking reagent: interaction of thrombospondin with fibronectin and collagen.

  1982cited by this paper
• Thrombospondin: synthesis and secretion by cells in culture

  1982cited by this paper
• Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems.

  1981cited by this paper
• Ca2+-mediated association of glycoprotein G (thrombinsensitive protein, thrombospondin) with human platelets.

  1980cited by this paper
• Isolation and characterization of a high molecular weight glycoprotein from human blood platelets.

  1978cited by this paper
• Histological Grading and Prognosis in Breast Cancer

  1957cited by this paper

• Role of anti-angiogenic factors in the pathogenesis of breast cancer: A review of therapeutic potential.

  2022cites this paper
• Angiogenesis in Breast Cancer Progression, Diagnosis, and Treatment

  2020cites this paper
• Human expression patterns: qualitative and quantitative analysis of thrombospondin‐1 under physiological and pathological conditions

  2018cites this paper
• Role of thrombospondin 1 in liver diseases

  2017cites this paper
• THBS1 is induced by TGFB1 in the cancer stroma and promotes invasion of oral squamous cell carcinoma.

  2016cites this paper
• Assessing Tumor Angiogenesis in Histological Samples.

  2016cites this paper
• Angiogenesis Protocols

  2016cites this paper
• Expresión de TSP-1 en carcinoma de mama

  2016influential citation
• Antiangiogenic mechanisms and factors in breast cancer treatment

  2016cites this paper
• Monoclonal antibodies to murine thrombospondin-1 and thrombospondin-2 reveal differential expression patterns in cancer and low antigen expression in normal tissues.

  2014cites this paper
• Effects of TSP-1-696 C/T polymorphism on bladder cancer susceptibility and clinicopathologic features.

  2014cites this paper
• TP53 Status is Associated with Thrombospondin1 Expression In vitro

  2013cites this paper
• TSP-1-1223 A/G Polymorphism as a Potential Predictor of the Recurrence Risk of Bladder Cancer in a Chinese Population

  2013cites this paper
• Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer

  2013cites this paper
• Thrombospondin-1 expression in breast cancer: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components.

  2012cites this paper
• The role of the tumor microenvironment in regulating angiogenesis.

  2012cites this paper
• Role of the protein tyrosine phosphatase DEP-1 in Src activation and the mediation of biological cell functions of endothelial and breast cancer cells

  2012cites this paper
• Rôle de la thrombospondine-1 dans la migration, l’invasion et la dissémination métastatique dans les carcinomes prostatiques et mammaires

  2012cites this paper
• Differential proteomic analysis of late-stage and recurrent breast cancer from formalin-fixed paraffin-embedded tissues.

  2011cites this paper
• Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers

  2011cites this paper
• Running Title: Correlated Expression of CD47 and SIRPA in Breast Cancer

  2010cites this paper
• Correlated Expression of CD47 and SIRPA in Bone Marrow and in Peripheral Blood Predicts Recurrence in Breast Cancer Patients

  2010cites this paper
• Clinical Cancer esearch ing , Diagnosis , Prognosis related Expression of CD 47 and SIRPA in Bone Marrow in Peripheral Blood Predicts Recurrence in R ast Cancer Patients

  2010cites this paper
• Cor and Bre

  2010cites this paper
• A PROTEOMIC ANALYSIS OF NEOPLASTIC PROGRESSION IN BREAST CANCER

  2010cites this paper
• Assessing tumor angiogenesis in histological samples.

  2009cites this paper
• Estrogen regulation of thrombospondin‐1 in human breast cancer cells

  2009cites this paper
• Regulation of tumor dormancy as a function of tumor‐mediated paracrine regulation of stromal Tsp‐1 and VEGF expression  

  2008cites this paper
• Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study.

  2007cites this paper
• Angiogenic characteristics of circulating and tumoural thrombospondin-1 in breast cancer.

  2007cites this paper
• TGF-131 and Ha-Ras collaborate in .modulating the phenotypic plasticity and mvaslveness of epithelial tumor cells

  2007cites this paper
• Breast Cancer Research Protocols

  2006cites this paper
• Quantitative angiogenesis in breast cancer.

  2006cites this paper
• Thrombospondin 1, thrombospondin 2 and the eye.

  2006cites this paper
• Extraction of RNA from archival tissues and measurement of thrombospondin-1 mRNA in normal, dysplastic, and malignant oral tissues.

  2006cites this paper
• Immunohistochemical expression of thrombospondin-1 in invasive vulvar squamous cell carcinoma.

  2005cites this paper
• CD31-Expression am Primärtumor und Nachweis hämatogen disseminierter Tumorzellen im Knochenmark von Brustkrebspatientinnen

  2005cites this paper
• Thrombospondin-1 expression in relation to p53 status and VEGF expression in human breast cancers.

  2004cites this paper
• Caveolin and Thrombospondin Expression During Hepatocellular Carcinogenesis

  2004cites this paper
• CD47 Mediates Killing of Breast Tumor Cells via Gi-Dependent Inhibition of Protein Kinase A

  2004cites this paper
• Mechanisms of thrombospondin-1-mediated metastasis and angiogenesis.

  2004cites this paper
• Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy

  2004cites this paper
• Mechanisms of Thrombospondin-1-Mediated Metastasis and Angiogenesis

  2004cites this paper
• Cloning and characterization of angiocidin, a tumor cell binding protein for thrombospondin‐1

  2004cites this paper
• The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression

  2004cites this paper
• Role of stromal thrombospondin-1 in motility and proteolytic activity of oral squamous cell carcinoma cells.

  2003cites this paper
• Thrombospondin-1 and Cutaneous Melanoma

  2003cites this paper
• Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast

  2002cites this paper
• Up-regulation of matrix metalloproteinase 9 by thrombospondin 1 in gastric cancer.

  2002cites this paper
• 2 Microscopic Assessment of Angiogenesis in Tumors

  2002cites this paper
• The New Angiotherapy

  2002influential citation
• Diagnostic and Prognostic Significance of Tumor Angiogenesis

  2002cites this paper
• Evidence of a bi-phasic effect of thrombospondin-1 on angiogenesis

  2002cites this paper
• Radial scars of the breast and breast carcinomas have similar alterations in expression of factors involved in vascular stroma formation.

  2002cites this paper
• Up-regulation of thrombospondin-1 gene by epidermal growth factor and transforming growth factor beta in human cancer cells--transcriptional activation and messenger RNA stabilization.

  2002cites this paper
• Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast

  2002cites this paper
• Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma.

  2001cites this paper
• Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1.

  2001cites this paper
• Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.

  2001cites this paper
• Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor

  2000cites this paper
• Thrombospondin-1 and -2 in Node-Negative Breast Cancer: Correlation with Angiogenic Factors, p53, Cathepsin D, Hormone Receptors and Prognosis

  2000cites this paper
• Oral cancer: role of the basement membrane in invasion.

  1999cites this paper
• Stromal expression of thrombospondin-1 is correlated with growth and metastasis of human gallbladder carcinoma.

  1999cites this paper
• Actions of heparin that may affect the malignant process

  1999cites this paper
• Stromal thrombospondin-1 expression is correlated with progression of esophageal squamous cell carcinomas.

  1999cites this paper
• Immunohistochemical study of thrombospondin and its receptors alpha root of beta 3 and CD36 in normal thyroid and in thyroid tumours.

  1999cites this paper
• [Thrombospondins, tumor angiogenesis and breast cancer].

  1999cites this paper
• Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.

  1999cites this paper
• Immunohistochemical study of thrombospondin and its receptors (cid:225) ’ (cid:226) 3 and CD36 in normal thyroid and in thyroid tumours

  1999cites this paper
• Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.

  1999cites this paper
• Exogenous thrombospondin stimulates the proliferation of non-thrombospondin-producing cells.

  1998cites this paper
• Plasma thrombospondin levels in patients with colorectal carcinoma

  1998cites this paper
• Localization of thrombospondin-1 and its cysteine-serine-valine-threonine-cysteine-glycine receptor in colonic anastomotic healing tissue.

  1998cites this paper
• Successful treatment by radiation and hormone therapy of isolated local recurrence of breast cancer 24 years after mastectomy accompanied by immune thrombocytopenia: a case report.

  1998cites this paper
• Focally regulated endothelial proliferation and cell death in human synovium.

  1998cites this paper
• Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression.

  1997cites this paper
• Thrombospondin-1 and -2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia.

  1997cites this paper
• Angiogenesis as a biologic and prognostic indicator in human breast carcinoma.

  1997cites this paper
• Histopathology and clinical assessment correlate with the cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) receptor of thrombospondin-1 in breast tumors.

  1997cites this paper
• Cellular expression of adhesion factors in childhood rhabdomyosarcoma.

  1997cites this paper
• Localization of thrombospondin in hepatocellular carcinoma

  1997cites this paper
• TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells.

  1996cites this paper
• Expression of Thrombospondin-1 in Cancer: A Role in Tumor Progression

  1996cites this paper
• The role of thrombospondin-1 in tumor progression and angiogenesis.

  1996cites this paper
• Scatter Factor As a Potential Tumor Angiogenesis Factor

  1996cites this paper
• Scatter factor binds to thrombospondin and other extracellular matrix components.

  1996cites this paper
• Immunohistochemical detection of thrombospondin-1 in formalin-fixed, paraffin-embedded tissue.

  1996cites this paper
• Heparin‐binding domain, type 1 and type 2 repeats of thrombospondin mediate its interaction with human breast cancer cells

  1996cites this paper
• Regulation of tumor growth and metastasis by thrombospondin‐1

  1996cites this paper
• Thrombospondin and transforming growth factor‐beta 1 increase expression of urokinase‐type plasminogen activator and plasminogen activator inhibitor‐1 in human MDA‐MB‐231 breast cancer cells

  1995cites this paper
• Distribution of thrombospondin and integrin αv in DCIS, invasive ductal and lobular human breast carcinomas

  1995cites this paper
• Scatter factor and angiogenesis.

  1995cites this paper
• Thrombospondin modulates human breast adenocarcinoma cell adhesion to human vascular endothelial cells.

  1995cites this paper
• Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines

  1994cites this paper
• Thrombospondin in human glomerulopathies. A marker of inflammation and early fibrosis.

  1994cites this paper
• Matrix-bound thrombospondin promotes angiogenesis in vitro

  1994cites this paper
• Plasma thrombospondin levels in patients with gynecologic malignancies

  1994cites this paper
• Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis.

  1994cites this paper
• Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.

  1994cites this paper
• The functions of thrombospondin and its involvement in physiology and pathophysiology.

  1993cites this paper